Skip to content

Jean-Michel Scherrmann

5 papers in the library · 136 citations · publishing 2008-2010

Papers

Sort Most recent Most cited

Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

The International Journal of Neuropsychopharmacology August 1, 2010 Nicolas Tournier, Lucie Chevillard, Bruno Mégarbane et al. 122 citations

Drug interaction with P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) may influence its tissue disposition including blood-brain barrier transport and result in potent drug-drug interactions. The limited data obtained using in-vitro models indicate that methadone, buprenorphine, and cannabinoids may interact with human P-gp; but almost nothing is known about drugs of abuse and...

Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.

Toxicological sciences : an official journal of the Society of Toxicology March 2010 Déborah Hirt, Julien Fonsart, Marie-Claude Menet et al.

The pharmacokinetics of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA) and its mains metabolites have never been modeled together. We therefore designed a model with which to analyze the pharmacokinetics of MDMA, 3,4-methylenedioxyamphetamine (MDA), 4-hydroxy-3-methoxymethamphetamine (HMMA), and 4-hydroxy-3-methoxyamphetamine (HMA) and to test the effect of covariates like...

Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).

Toxicology and Applied Pharmacology December 15, 2009 Julien Fonsart, Marie-Claude Menet, Marcel Debray et al.

The use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has increased in recent years; it can lead to life-threatening hyperthermia and serotonin syndrome. Human and rodent males appear to be more sensitive to acute toxicity than are females. MDMA is metabolized to five main metabolites by the enzymes CYP1A2, CYP2D and COMT. Little is presently known about sex-dependent differences in the...

Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.

Journal of Pharmaceutical Sciences December 1, 2009 Nicolas Tournier, Pascal André, Sandy Blondeel et al. 14 citations

The (99m)Tc-tricarbonyl core may be used as an ideal tool for gamma-labeling ligands in noninvasive SPECT imaging. However, most (99m)Tc-tricarbonyl-labeled agents have difficulty crossing the blood-brain barrier (BBB). We radiolabeled the neuroactive indole ibogaine with (99m)Tc-tricarbonyl and measured its transport into the mouse brain by in situ brain perfusion. We measured the interactions...

DOI: 10.1002/jps.21771 (opens in new tab) Full text (opens in new tab) Brain imaging Neuroimaging Molecular imaging Imaging agents +23

Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Toxicology and Applied Pharmacology July 1, 2008 Julien Fonsart, Marie-Claude Menet, Xavier Declèves et al.

The use of the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has been associated with unexplained deaths. Male humans and rodents are more sensitive to acute toxicity than are females, including a potentially lethal hyperthermia. MDMA is highly metabolized to five main metabolites, by the enzymes CYP1A2 and CYP2D. The major metabolite in rats,...